Cargando…
ACP-ADA: A Boosting Method with Data Augmentation for Improved Prediction of Anticancer Peptides
Cancer is the second-leading cause of death worldwide, and therapeutic peptides that target and destroy cancer cells have received a great deal of interest in recent years. Traditional wet experiments are expensive and inefficient for identifying novel anticancer peptides; therefore, the development...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9603247/ https://www.ncbi.nlm.nih.gov/pubmed/36293050 http://dx.doi.org/10.3390/ijms232012194 |
_version_ | 1784817503188287488 |
---|---|
author | Bhattarai, Sadik Kim, Kyu-Sik Tayara, Hilal Chong, Kil To |
author_facet | Bhattarai, Sadik Kim, Kyu-Sik Tayara, Hilal Chong, Kil To |
author_sort | Bhattarai, Sadik |
collection | PubMed |
description | Cancer is the second-leading cause of death worldwide, and therapeutic peptides that target and destroy cancer cells have received a great deal of interest in recent years. Traditional wet experiments are expensive and inefficient for identifying novel anticancer peptides; therefore, the development of an effective computational approach is essential to recognize ACP candidates before experimental methods are used. In this study, we proposed an Ada-boosting algorithm with the base learner random forest called ACP-ADA, which integrates binary profile feature, amino acid index, and amino acid composition with a 210-dimensional feature space vector to represent the peptides. Training samples in the feature space were augmented to increase the sample size and further improve the performance of the model in the case of insufficient samples. Furthermore, we used five-fold cross-validation to find model parameters, and the cross-validation results showed that ACP-ADA outperforms existing methods for this feature combination with data augmentation in terms of performance metrics. Specifically, ACP-ADA recorded an average accuracy of 86.4% and a Mathew’s correlation coefficient of 74.01% for dataset ACP740 and 90.83% and 81.65% for dataset ACP240; consequently, it can be a very useful tool in drug development and biomedical research. |
format | Online Article Text |
id | pubmed-9603247 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-96032472022-10-27 ACP-ADA: A Boosting Method with Data Augmentation for Improved Prediction of Anticancer Peptides Bhattarai, Sadik Kim, Kyu-Sik Tayara, Hilal Chong, Kil To Int J Mol Sci Article Cancer is the second-leading cause of death worldwide, and therapeutic peptides that target and destroy cancer cells have received a great deal of interest in recent years. Traditional wet experiments are expensive and inefficient for identifying novel anticancer peptides; therefore, the development of an effective computational approach is essential to recognize ACP candidates before experimental methods are used. In this study, we proposed an Ada-boosting algorithm with the base learner random forest called ACP-ADA, which integrates binary profile feature, amino acid index, and amino acid composition with a 210-dimensional feature space vector to represent the peptides. Training samples in the feature space were augmented to increase the sample size and further improve the performance of the model in the case of insufficient samples. Furthermore, we used five-fold cross-validation to find model parameters, and the cross-validation results showed that ACP-ADA outperforms existing methods for this feature combination with data augmentation in terms of performance metrics. Specifically, ACP-ADA recorded an average accuracy of 86.4% and a Mathew’s correlation coefficient of 74.01% for dataset ACP740 and 90.83% and 81.65% for dataset ACP240; consequently, it can be a very useful tool in drug development and biomedical research. MDPI 2022-10-13 /pmc/articles/PMC9603247/ /pubmed/36293050 http://dx.doi.org/10.3390/ijms232012194 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Bhattarai, Sadik Kim, Kyu-Sik Tayara, Hilal Chong, Kil To ACP-ADA: A Boosting Method with Data Augmentation for Improved Prediction of Anticancer Peptides |
title | ACP-ADA: A Boosting Method with Data Augmentation for Improved Prediction of Anticancer Peptides |
title_full | ACP-ADA: A Boosting Method with Data Augmentation for Improved Prediction of Anticancer Peptides |
title_fullStr | ACP-ADA: A Boosting Method with Data Augmentation for Improved Prediction of Anticancer Peptides |
title_full_unstemmed | ACP-ADA: A Boosting Method with Data Augmentation for Improved Prediction of Anticancer Peptides |
title_short | ACP-ADA: A Boosting Method with Data Augmentation for Improved Prediction of Anticancer Peptides |
title_sort | acp-ada: a boosting method with data augmentation for improved prediction of anticancer peptides |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9603247/ https://www.ncbi.nlm.nih.gov/pubmed/36293050 http://dx.doi.org/10.3390/ijms232012194 |
work_keys_str_mv | AT bhattaraisadik acpadaaboostingmethodwithdataaugmentationforimprovedpredictionofanticancerpeptides AT kimkyusik acpadaaboostingmethodwithdataaugmentationforimprovedpredictionofanticancerpeptides AT tayarahilal acpadaaboostingmethodwithdataaugmentationforimprovedpredictionofanticancerpeptides AT chongkilto acpadaaboostingmethodwithdataaugmentationforimprovedpredictionofanticancerpeptides |